NIH-sponsored trial of Lassa vaccine opens

News Healthcare & Pharma General Updates

Date: 17th Mar, 2025 Source: National Institutes of Health (NIH) Country: USA Original Source

Brief

On Monday, March 17, 2025, the National Institutes of Health (NIH) issued an update regarding NIH-sponsored trial of Lassa vaccine opens. The clinical trial aims to test the safety and immunogenicity of a candidate vaccine to prevent Lassa fever, which is a viral hemorrhagic disease that can be fatal and causes permanent hearing loss in up to one-third of those who contract it.

This content is restricted.

Highlights content goes here...

This content is restricted.

National Institutes of Health (NIH)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

NIH-sponsored trial of Lassa vaccine opens

Brief

National Institutes of Health (NIH)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

NIH-sponsored trial of Lassa vaccine opens

Brief

National Institutes of Health (NIH)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.